XPro1595

XPro1595 · Inmune Bio, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XPro1595, covering 2026-02-27 to 2026-06-29. Get the full timeline:

Most recent: Clinical Trial Results: A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation [Phase 2]